ClinicalTrials.Veeva

Menu

Effects of NR Supplementation on Metabolic Flexibility in Zone 2 Training

Z

ZHANG Jiaqi

Status

Not yet enrolling

Conditions

Health Adult Subjects

Treatments

Dietary Supplement: Nicotinamide Riboside (NR)

Study type

Interventional

Funder types

Other

Identifiers

NCT07344636
SBRE-25-0349

Details and patient eligibility

About

Zone 2 training, a low-intensity endurance exercise performed at approximately 66-80% of VO₂max or near the first ventilatory threshold, has gained popularity for improving aerobic capacity, fat metabolism, and mitochondrial efficiency. It preserves glycogen stores and delays fatigue, making it an essential training method for both athletes and recreational exercisers. Nicotinamide adenine dinucleotide (NAD) is a vital metabolite that regulates cellular energy metabolism and redox homeostasis. It participates in oxidative reactions within the tricarboxylic acid cycle and electron transport chain, sustaining ATP synthesis and mitochondrial efficiency. Exercise influences multiple pathways of NAD metabolism, altering the NAD⁺/NADH ratio and thereby affecting energy production and fatigue resistance. Studies have shown that both aerobic exercise and NAD precursor supplementation (e.g., nicotinamide riboside [NR]) can elevate body NAD levels and enhance mitochondrial function, though findings remain inconsistent due to variations in dosage and participants' characteristics. This study aims to investigate how acute NR supplementation interacts with Zone 2 cycling training in adults. Specifically, it examines the temporal and dose-dependent effects of NR supplementation on metabolic flexibility and exercise performance. The results may clarify the potential synergistic benefits of combining NAD supplementation with low-intensity endurance training to improve aerobic adaptability.

Enrollment

16 estimated patients

Sex

All

Ages

18 to 80 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Over 18 years old
  • BMI <30 kg/m2

Exclusion criteria

  • Present of health conditions that contraindicate participation in exercise training, such as a history of cardiovascular disease, cancer, or musculoskeletal disorders
  • Currently taking vitamin B supplements and/or NAD precursors
  • Taking medication that may affect the test results

Trial design

Primary purpose

Other

Allocation

Randomized

Interventional model

Crossover Assignment

Masking

Double Blind

16 participants in 3 patient groups

600 mg
Experimental group
Treatment:
Dietary Supplement: Nicotinamide Riboside (NR)
Dietary Supplement: Nicotinamide Riboside (NR)
300 mg
Experimental group
Treatment:
Dietary Supplement: Nicotinamide Riboside (NR)
Dietary Supplement: Nicotinamide Riboside (NR)
0 mg
No Intervention group

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems